Skip to main content
. 2016 Nov 8;7(49):81223–81240. doi: 10.18632/oncotarget.13219

Figure 2. Kaplan-Meier survival curve according to USP33 expression in CRCLM tissues.

Figure 2

(A) The 5-year overall survival in the patients with high USP33 expression and low USP33 expression were 48.6% and 25.6%, respectively (P = 0.001). (B) The 3-year disease free survival of patients in the high USP33 expression group and low USP33 expression group were 59.8% and 28.7%, respectively (P < 0.001).